St. Luke’s Medical Center marked World Pneumonia Day with a two‑day hybrid respiratory‑care campaign, sounding the alarm on pneumonia: the Philippines’ leading communicable‑disease killer and one of the world’s top five causes of death.
Pneumonia inflames lung air sacs, filling them with fluid or pus and making breathing difficult. It is treatable and preventable through early consultation, proper medication, and vaccination, yet globally, one child under five dies from pneumonia every 43 seconds.
Hosted at the Henry Sy, Sr. Auditorium, the November 11‑12 event partnered with the Philippine College of Chest Physicians, Philippine College of Physicians, Philippine Society for Microbiology and Infectious Diseases, Philippine Pediatric Society, PneumoLight, and Every Breath Counts Coalition for both on‑site and virtual participants. The INFACTivity session for healthcare workers covered aging lungs, immune vulnerability, post‑infection recovery, and respiratory‑illness prevention, while the free PneumoLight Conference discussed shifting infection trends, advanced diagnostics, post‑pneumonia rehabilitation, and multidisciplinary care. Speakers included St. Luke’s pulmonology head Dr. Guinevere N. Dy‑Agra, pneumonia researcher Dr. Catia Cilloniz, and University of Pittsburgh professor Dr. Charles dela Cruz.
St. Luke’s also lit its facade blue for the global PneumoLight illumination movement, joining landmarks in over 40 countries to raise public support for pneumonia prevention, equitable healthcare, and immunization.
The hospital urged anyone with persistent respiratory symptoms — high fever, shortness of breath, chest pain when breathing, or severe productive cough — to see a pulmonologist or infectious‑disease specialist right away. Through its Institute of Pulmonary Medicine, St. Luke’s offers comprehensive lung screening, pulmonary function testing, targeted antimicrobial care, and adult‑and‑child vaccination against pneumococcal and seasonal viral infections.
